New Delhi, 11th June 2024: Informa Markets in India proudly announces the launch of its much-awaited event, India Health, scheduled from June 13th to 15th, 2024, at the India International Convention Centre (IICC) in Dwarka, New Delhi. This inaugural event marks a pivotal moment for the healthcare industry, promising to create benchmarks and collaborative advancement.
Born of the esteemed legacy of globally renowned event Arab Health, India Health aspires to serve as a comprehensive platform for the entire healthcare industry under one platform. With projections indicating that India’s healthcare sector will soar to a value of US$638 billion by 2025, the imperative for such a gathering becomes even more evident. India Health aims to facilitate the convergence of key stakeholders, empowering businesses to contribute to the delivery of equitable healthcare services across the nation.
The premier edition of India Health will showcase over 300 leading global and domestic brands across Medical Equipment & Devices, Orthopaedics & Physiotherapy, Imaging & Diagnostics, Healthcare & General Services, IT Systems & Solutions, Healthcare Infrastructure & Assets, Wellness & Prevention, and more. KLS Martin group, Medikabazaar, Midmark, Narang Medical LTD, Zimmer Medizinsysteme Gmbh, Med Freshe Private Limited, Palakkad Surgical Industries Pvt Ltd, Nilkamal Limited and the Embassy of Hungary (as Country Partner) have already confirmed their participation. The show is Supported by esteemed associations such as ADMI (Association of Diagnostics Manufacturers of India) and MTAI (Medical Technology Association of India), with AHPI (Association of Healthcare Providers India) and Frost & Sullivan as knowledge partners.
Emphasizing the significance of India Health, Mr Yogesh Mudras, Managing Director of Informa Markets in India, stated, “India Health is the heartbeat of our shows. There’s never been a more opportune moment to launch such a groundbreaking event with India’s healthcare sector rapidly expanding and having reached a value of USD 372 billion in 2023, driven by both private sector and government initiatives. This has been driven by incremental healthcare coverage, investments, and enhanced services from both public and private sectors. Government initiatives, such as relaxed FDI norms, Ayushman Bharat Digital Mission, an initiative to make healthcare quick and accessible to all, startup promotion policies, and bolstered R&D efforts, alongside refined IPR regulations, have fostered a conducive business environment.
India Health aligns seamlessly with the ‘Make in India’ campaign, focusing on vital sectors like healthcare, pharmaceuticals, biotechnology, and chemicals. The event stands at the convergence for advancing healthcare excellence, innovation, and promoting collaboration, all while addressing the nation’s health needs equitably. With its inaugural edition, we anticipate a profound impact and extend our gratitude to all stakeholders for their unwavering support,” he added.
India Health will attract a distinguished visitor profile comprising Hospital Purchase Managers, CEOs, Directors, biomedical engineers, consultants, distributors, doctors, regulators, and policymakers. The event will also feature the official country pavilion of Hungary, enriching attendees with diverse perspectives and innovations.
Enhancing the attendee experience, India Health will include a Transformation Zone showcasing start-up companies and innovators with transformative products and new launches. Additionally, start-up pavilions will provide domestic entrepreneurs the opportunity to engage with industry experts and potential investors.
A robust 3-day conference programme with the theme of ‘Converging the Healthcare World for Limitless Possibilities Outcomes’ will take place on the sidelines of the main show. Comprising 15 conferences, the programme will cover a wide and critical range of topics crucial for understanding and shaping the future of the healthcare industry in India with top-notch medical speakers in attendance. Some of the topics include ‘Accelerating Growth of Indian Healthcare Industry – Racing towards $550 Bn+ by 2030 (by -Frost & Sullivan); Market entry in Healthcare in India – Success stories, Challenges and best practices’ (presented by Country Partner Hungary); ‘Technological Advances in the Comprehensive and less invasive surgical management of Cardiovascular and Thoracic diseases; ‘Innovations in Fem Hygiene Industry and Future Trends’; ‘Diagnostic Innovations Shaping the Future of Indian Healthcare’: ‘AI-driven Digital Diagnostics’; ‘Growth and Value Creation in Healthcare with Digital Transformation’; ‘Revolutionizing Healthcare: The Role of Robotics in Surgery and Beyond’; ‘Diagnostic Innovations Shaping the Future of Indian Healthcare’; ‘Preventive Genetics and Precision Medicine’; ‘Safeguarding the patients from surgical site infection’; ‘Driving Healthcare Innovation Through Entrepreneurship: Strategies for Success’; ‘Charting the Course: Exploring Growth Prospects in India’s Medical Device Market by 2030’; and ‘Regulatory environment and Policy Implications and Training the Healthcare Workforce of the Future’, among others.
The sector, at a glance:
* India ranks as the 4th largest medical device market globally.
* The industry is projected to reach a valuation of US$638 billion by 2025
* Public health spending is projected to grow to 2.5% of the country’s GDP.
* The Indian medical tourism industry is estimated to surpass US$42 billion by 2032.
* Over $200 billion is earmarked for medical infrastructure spending by 2024.
* The medtech market in India is projected to reach $50 billion by 2025.
* Non-communicable diseases account for 7 out of the top causes of death in India.
* 70% of the population resides in rural areas, with access to less than 30% of healthcare infrastructure.
Leave a Reply